Report Categories
View AllRecent Articles
View All
Is Caseys CASY stock a viable buying opportunity 083 20260420
TELO Telomir Pharmaceuticals gains slightly even as Q4 2025 EPS lands far below analyst consensus estimates
elf Beauty ELF EPS surges 70 above estimates but stock drops 8 signaling investor concerns beyond the beat
Dyne DYN Stock Next Week Technical Weakness 20260420
ACN Accenture delivers Q1 2026 EPS beat and 74 percent year over year revenue growth but shares drop 131 percent
FCC Unprecedented Broadcast License Renewal Mandate for US Major Media Assets
SPDR Gold Trust GLD Reassessing Allocations Inflation Hedge Narrative vs LowCorrelation Portfolio Utility
The credit profile of Zurn Elkay ZWS revealed Q1 2026 Better Than Expected
How Mexico MXF is solving the problems its peers cannot Steady 20260508
Oramed Pharmaceuticals ORMP Stock Slides 074 Support at 446 20260515
Should You Sell Malibu Boats MBUU After 365 Drop 20260515
Why Iron Horse IRHOR Just Surged 485 Key Levels Ahead 20260517
Luxury Industry Grapples with Inherent Contradictions as Exclusivity Evolves
Spyre Therapeutics SYRE Stock Analysis Climbs 796 Eyes on 7552 20260520
BrownBrown BRO Q1 2026 Earnings Surprise EPS 139 Up Significant
Citigroup Upgrades Arthur J Gallagher to Buy Citing Valuation and Cyclical Recovery
Vermilion Energy Inc VET Declines 238 as Price Approaches Key Support Level
Irans Potential Tariffs on Hormuz Internet Cables Could Raise Europes Connectivity Costs and Risks
Frankfurt Airports New Sky Line Shuttle Faces Early Disruption Passengers Rerouted to Buses
Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment
Novartis Upgrades FullYear Outlook on Strong Portfolio Momentum
SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags
Vickers Insider Trading Report Highlights Buyers and Sellers for May 27 2026
ZURA Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss
TUSK Q1 2026 Earnings EPS of 010 Amid Mixed Results Stock Declines 469
PHAR Q1 2026 Earnings EPS Misses Estimates by Wide Margin
TVGN Q4 2025 Earnings NarrowerThanExpected Loss but No Revenue Growth Keeps Stock Under Pressure
ELTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline
Macerich MAC Nears Resistance After Modest Gains Supported by Real Estate Sector Momentum
Empire Petroleum EP Edges Lower While Holding Key Support Zone
Millennium Group International MGIH Edges Lower Amidst Consolidation Near Key Support
LivePerson Inc LPSN Edges Higher as Stock Holds Above Key Support
External Links
VSTM Verastem quarterly report shows zero revenue but management highlights clinical trial progress and upcoming milestones
Metro Bank Faces Investor Backlash Over CEOs Potential 60M Bonus Plan
SVCO Q1 2026 Earnings BetterThanExpected Loss Drives Modest Stock Gain
SLGN Silgan Holdings notches narrow Q1 2026 earnings beat shares rise nearly two percent on upbeat investor reaction
NRIX Nurix shares fall 355 despite 54 revenue surge Q1 earnings miss raises profitability concerns
KT Corporation KT EPS beats by 158 but shares slide 1 as investors weigh outlook risks
CRS Carpenter delivers 41 percent Q1 2026 EPS upside versus consensus estimates with shares notching modest daily gains
CrossAsset Market Volatility Triggered by Escalating Iran Conflict
SLNG Stabilis Solutions posts narrower Q4 2025 loss than analyst estimates shares rise modestly after its latest quarterly earnings release
SNPS Synopsys reports Q1 2026 EPS above consensus estimates shares post small daily gain